Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme I Injection for Vascular Aging
ChiCTR2600116222Phase 4Recruiting
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nicotinamide adenine dinucleotide in vascular ageing (VA) and arteriosclerosis (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoint: Change in endothelial function at day 28. Started Jan 2026; status: recruiting.
02
Drugs
nicotinamide adenine dinucleotide
03
Conditions
vascular ageing (VA)arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2600116222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600116222.